Organization
Shanghai Juncell Therapeutics
14 clinical trials
Clinical trial
An Open, Single-armed, Phase I Study to Evaluate the Safety and Efficacy Using Autologous TIL in Patients With Advanced Malignant Solid TumorsStatus: Recruiting, Estimated PCD: 2024-11-07
Clinical trial
A Clinical Safety and Efficacy Study on TIL for the Treatment of GliomaStatus: Recruiting, Estimated PCD: 2024-12-30
Clinical trial
A Clinical Safety and Efficacy Study on TIL for the Treatment of r/r Gastrointestinal TumorsStatus: Recruiting, Estimated PCD: 2024-12-30
Clinical trial
A Clinical Safety and Efficacy Study on TIL for the Treatment of Advanced Solid TumorsStatus: Recruiting, Estimated PCD: 2024-12-22
Clinical trial
A Clinical Study on Tumor Infiltrating Lymphocytes for the Treatment of Advanced Solid TumorsStatus: Recruiting, Estimated PCD: 2024-12-10
Clinical trial
A Clinical Study on TIL for the Treatment of Advanced MelanomaStatus: Recruiting, Estimated PCD: 2024-09-25
Clinical trial
A Clinical Study on TIL for the Treatment of Advanced Hepatobiliary-Pancreatic CancersStatus: Recruiting, Estimated PCD: 2024-09-25
Clinical trial
An Open, Single-armed, Phase Ib Study to Evaluate the Safety and Efficacy Using Autologous TIL in Patients With Advanced MelanomaStatus: Recruiting, Estimated PCD: 2025-04-06
Clinical trial
A Clinical Study on TIL Engineered With Membrane-Binding Cytokine for the Treatment of Advanced Gynecologic TumorsStatus: Recruiting, Estimated PCD: 2024-03-10
Clinical trial
A Clinical Study on Signal Switch Receptor Modified TIL for the Treatment of Advanced Gynecologic TumorsStatus: Recruiting, Estimated PCD: 2024-09-25
Clinical trial
A Phase I Study on Engineering Tumor Infiltrating Lymphocytes Injection (GC203 TIL) for the Treatment of Advanced Malignant Solid TumorsStatus: Not yet recruiting, Estimated PCD: 2025-11-01
Clinical trial
A Clinical Study on TIL for the Treatment of Advanced Breast CancerStatus: Recruiting, Estimated PCD: 2024-12-20
Clinical trial
An Open, Single-armed, Phase Ib Study to Evaluate the Safety and Efficacy Using Autologous TIL in Patients With Non-Small Cell Lung CancerStatus: Not yet recruiting, Estimated PCD: 2025-01-01
Clinical trial
A Study on Tumor Infiltrating Lymphocytes for the Treatment of Advanced Solid TumorsStatus: Recruiting, Estimated PCD: 2026-06-30